| 1. |
- Gapstur, S. M., et al.
(author)
-
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
- 2015
-
In: The Lancet. - 1474-547X. ; 385:9980, s. 1835-1842
-
Journal article (peer-reviewed)abstract
- Background Half the epidemiological studies with information about menopausal hormone therapy and ovarian cancer risk remain unpublished, and some retrospective studies could have been biased by selective participation or recall. We aimed to assess with minimal bias the effects of hormone therapy on ovarian cancer risk. Methods Individual participant datasets from 52 epidemiological studies were analysed centrally. The principal analyses involved the prospective studies (with last hormone therapy use extrapolated forwards for up to 4 years). Sensitivity analyses included the retrospective studies. Adjusted Poisson regressions yielded relative risks (RRs) versus never-use. Findings During prospective follow-up, 12 110 postmenopausal women, 55% (6601) of whom had used hormone therapy, developed ovarian cancer. Among women last recorded as current users, risk was increased even with <5 years of use (RR 1.43, 95% CI 1.31-1.56; p<0.0001). Combining current-or-recent use (any duration, but stopped <5 years before diagnosis) resulted in an RR of 1.37 (95% CI 1.29-1.46; p<0.0001); this risk was similar in European and American prospective studies and for oestrogen-only and oestrogen-progestagen preparations, but differed across the four main tumour types (heterogeneity p<0.0001), being definitely increased only for the two most common types, serous (RR 1.53, 95% CI 1.40-1.66; p<0.0001) and endometrioid (1.42, 1.20-1.67; p<0.0001). Risk declined the longer ago use had ceased, although about 10 years after stopping long-duration hormone therapy use there was still an excess of serous or endometrioid tumours (RR 1.25, 95% CI 1.07-1.46, p=0.005). Interpretation The increased risk may well be largely or wholly causal; if it is, women who use hormone therapy for 5 years from around age 50 years have about one extra ovarian cancer per 1000 users and, if its prognosis is typical, about one extra ovarian cancer death per 1700 users.
|
|
| 2. |
- Matthews, V B, et al.
(author)
-
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance.
- 2010
-
In: Diabetologia. - : Springer Science and Business Media LLC. - 1432-0428 .- 0012-186X. ; 53:11, s. 2431-2441
-
Journal article (peer-reviewed)abstract
- AIMS/HYPOTHESIS: The role of IL-6 in the development of obesity and hepatic insulin resistance is unclear and still the subject of controversy. We aimed to determine whether global deletion of Il6 in mice (Il6 (-/-)) results in standard chow-induced and high-fat diet (HFD)-induced obesity, hepatosteatosis, inflammation and insulin resistance. METHODS: Male, 8-week-old Il6 (-/-) and littermate control mice were fed a standard chow or HFD for 12 weeks and phenotyped accordingly. RESULTS: Il6 (-/-) mice displayed obesity, hepatosteatosis, liver inflammation and insulin resistance when compared with control mice on a standard chow diet. When fed a HFD, the Il6 (-/-) and control mice had marked, equivalent gains in body weight, fat mass and ectopic lipid deposition in the liver relative to chow-fed animals. Despite this normalisation, the greater liver inflammation, damage and insulin resistance observed in chow-fed Il6 (-/-) mice relative to control persisted when both were fed the HFD. Microarray analysis from livers of mice fed a HFD revealed that genes associated with oxidative phosphorylation, the electron transport chain and tricarboxylic acid cycle were uniformly decreased in Il6 (-/-) relative to control mice. This coincided with reduced maximal activity of the mitochondrial enzyme beta-hydroxyacyl-CoA-dehydrogenase and decreased levels of mitochondrial respiratory chain proteins. CONCLUSIONS/INTERPRETATION: Our data suggest that IL-6 deficiency exacerbates HFD-induced hepatic insulin resistance and inflammation, a process that appears to be related to defects in mitochondrial metabolism.
|
|
| 3. |
- Fuente, A., et al.
(author)
-
PDRs4All IX. Sulfur elemental abundance in the Orion Bar
- 2024
-
In: Astronomy and Astrophysics. - 0004-6361 .- 1432-0746. ; 687
-
Journal article (peer-reviewed)abstract
- Context . One of the main problems in astrochemistry is determining the amount of sulfur in volatiles and refractories in the interstellar medium. The detection of the main sulfur reservoirs (icy H2S and atomic gas) has been challenging, and estimates are based on the reliability of models to account for the abundances of species containing less than 1% of the total sulfur. The high sensitivity of the James Webb Space Telescope provides an unprecedented opportunity to estimate the sulfur abundance through the observation of the [S I] 25.249 µm line. Aims. Our aim is to determine the amount of sulfur in the ionized and warm molecular phases toward the Orion Bar as a template to investigate sulfur depletion in the transition between the ionized gas and the molecular cloud in HII regions. Methods . We used the [S III] 18.7 µm, [S IV] 10.5 µm, and [S l] 25.249 µm lines to estimate the amount of sulfur in the ionized and molecular gas along the Orion Bar. For the theoretical part, we used an upgraded version of the Meudon photodissociation region (PDR) code to model the observations. New inelastic collision rates of neutral atomic sulfur with ortho- and para- molecular hydrogen were calculated to predict the line intensities. Results . The [S III] 18.7 µm and [S IV] 10.5 µm lines are detected over the imaged region with a shallow increase (by a factor of 4) toward the HII region. This suggests that their emissions are partially coming from the Orion Veil. We estimate a moderate sulfur depletion, by a factor of ∼2, in the ionized gas. The corrugated interface between the molecular and atomic phases gives rise to several edge-on dissociation fronts we refer to as DF1, DF2, and DF3. The [S l] 25.249 µm line is only detected toward DF2 and DF3, the dissociation fronts located farthest from the HII region. This is the first ever detection of the [S l] 25.249 µm line in a PDR. The detailed modeling of DF3 using the Meudon PDR code shows that the emission of the [S l] 25.249 µm line is coming from warm (>40 K) molecular gas located at AV ∼1–5 mag from the ionization front. Moreover, the intensity of the [S l] 25.249 µm line is only accounted for if we assume the presence of undepleted sulfur. Conclusions . Our data show that sulfur remains undepleted along the ionic, atomic, and molecular gas in the Orion Bar. This is consistent with recent findings that suggest that sulfur depletion is low in massive star-forming regions because of the interaction of the UV photons coming from the newly formed stars with the interstellar matter.
|
|
| 4. |
|
|
